Delivery Order SPE2DB24D2105-SPE2DB25FAPTX
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for $4,992.61 on November 18, 2025, for the supply of Verquvo 10 mg tablets (90-count supply). This is a firm fixed-price delivery order with no set-aside designation, awarded through competitive procurement. The contract is scheduled for ultimate completion on November 19, 2025, with performance based at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,227.26 to AmerisourceBergen Drug Corp for the supply of Verquvo 10 mg tablets (30-count packaging). The award, made on July 8, 2025, with an ultimate completion date of July 9, 2025, is structured as a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. Performance will be executed from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where...
- The Defense Logistics Agency awarded a $1,243.00 delivery order to AmerisourceBergen Drug Corp for VERQUVO 10 mg tablets (30-count units) on April 22, 2025, with completion scheduled for April 23, 2025. This firm fixed-price, non-set-aside contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The pharmaceutical products will be delivered to AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 2, 2025, for the supply of Verquvo 10 mg tablets (quantity 90) at a firm fixed price of $12,569.21, with completion targeted for September 3, 2025. This contract represents a non-set-aside, competitively awarded delivery order executed under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The performance location is AmerisourceBergen's corporate office in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 25, 2025, for the supply of Verquvo 5 mg tablets (14-count units) with a ceiling value of $7,605.92 under a firm fixed price contract. This is a non-set-aside, competitively awarded delivery order with an ultimate completion date of September 26, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for federal medical...
- The Defense Logistics Agency awarded a $2,886.90 delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of Verquvo 2.5 mg tablets (30-count units). This firm fixed price, non-set-aside contract is expected to be completed by August 18, 2025, with performance taking place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
- The Defense Logistics Agency awarded a $7,091.65 delivery order to AmerisourceBergen Drug Corp for VERQUVO 5 mg tablets (14-count packaging) on November 3, 2025, with completion targeted for November 4, 2025. This firm fixed-price contract was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor...
- The Defense Logistics Agency awarded a delivery order valued at $3,721.73 to AmerisourceBergen Drug Corp for Verquvo 5 mg tablets (14-count packaging) on July 25, 2025, with an ultimate completion date of July 28, 2025. This firm fixed-price delivery order is non-set-aside and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, fulfills this requirement as...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on November 18, 2025, with a ceiling value of $1,620.01 for 90-count tablets of Verquvo 10 mg. The contract is structured as a firm fixed-price delivery order with an ultimate completion date of November 19, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. This award was not set-aside and was competitively awarded, demonstrating AmerisourceBergen's capability to...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for VERQUVO 10 mg tablets (30-count units) valued at $2,749.50 under a firm fixed-price contract type. The award was made on June 16, 2025, with an ultimate completion date of June 17, 2025. This delivery order is not set-aside and was competitively awarded to the Conshohocken, Pennsylvania-based pharmaceutical distributor. AmerisourceBergen Drug Corp serves as a critical vendor within the federal medical...
- SPE2DB24D2105Indefinite Delivery Contract
- SPE2DB24D2105-SPE2DB25FAPTXDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $8,669.85 to AmerisourceBergen Drug Corp for the supply of Verquvo 10 mg tablets (30-count packaging) on June 13, 2025, with completion scheduled for June 16, 2025. This competitively awarded, firm fixed price delivery order carries no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, fulfills this order as part of its broader federal medical procurement responsibilities supporting military and veteran healthcare systems. This delivery order is executed under AmerisourceBergen Drug Corp's Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and extending through December 2026. The parent IDC enables the contractor to supply an extensive range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including specialty medications, brand-name and generic drugs, vaccines, and related medical commodities. AmerisourceBergen Drug Corp's continued performance under this vehicle demonstrates its capability to meet federal procurement requirements through open competition and positions it as a key provider as the DLA Troop Support pursues Pharmaceutical Prime Vendor Global Program Generation V contracts.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $8.7k | 6/13/25 |